185 related articles for article (PubMed ID: 33755900)
1. Efficient Generation of iPSC-Derived Hematoendothelial Progenitors and Specification Toward T cell Lineage.
Suwanpitak S; Promnakhon N; Netsrithong R; Wattanapanitch M
Methods Mol Biol; 2022; 2454():423-442. PubMed ID: 33755900
[TBL] [Abstract][Full Text] [Related]
2. Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells.
Netsrithong R; Suwanpitak S; Boonkaew B; Trakarnsanga K; Chang LJ; Tipgomut C; Vatanashevanopakorn C; Pattanapanyasat K; Wattanapanitch M
Stem Cell Res Ther; 2020 Nov; 11(1):481. PubMed ID: 33176890
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cell (iPSC) from NY-ESO-I-specific cytotoxic T cells isolated from the melanoma patient with minor HLAs: The practical pilot study for the adoptive immunotherapy for melanoma using iPSC technology.
Itoh M; Kawagoe S; Nakagawa H; Asahina A; Okano HJ
Exp Dermatol; 2023 Feb; 32(2):126-134. PubMed ID: 36222007
[TBL] [Abstract][Full Text] [Related]
4. Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling.
Makino K; Long MD; Kajihara R; Matsueda S; Oba T; Kanehira K; Liu S; Ito F
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101945
[TBL] [Abstract][Full Text] [Related]
5. Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells.
Good ML; Vizcardo R; Maeda T; Tamaoki N; Malekzadeh P; Kawamoto H; Restifo NP
J Vis Exp; 2019 Oct; (152):. PubMed ID: 31710026
[TBL] [Abstract][Full Text] [Related]
6. Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory.
Saito H; Okita K; Chang AE; Ito F
Cancer Res; 2016 Jun; 76(12):3473-83. PubMed ID: 27197199
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles of IL-7 and stem cell factor in the OP9-DL1 T-cell differentiation culture system.
Wang H; Pierce LJ; Spangrude GJ
Exp Hematol; 2006 Dec; 34(12):1730-40. PubMed ID: 17157170
[TBL] [Abstract][Full Text] [Related]
8. Redifferentiation of Adaptive Naïve-Like CTL from T-Cell-Derived iPSC.
Kawai Y; Kaneko S
Methods Mol Biol; 2019; 2048():71-75. PubMed ID: 31396930
[TBL] [Abstract][Full Text] [Related]
9. Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy.
Kawai Y; Kawana-Tachikawa A; Kitayama S; Ueda T; Miki S; Watanabe A; Kaneko S
Mol Ther; 2021 Oct; 29(10):3027-3041. PubMed ID: 34023508
[TBL] [Abstract][Full Text] [Related]
10. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
[TBL] [Abstract][Full Text] [Related]
11. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.
Lei F; Zhao B; Haque R; Xiong X; Budgeon L; Christensen ND; Wu Y; Song J
Cancer Res; 2011 Jul; 71(14):4742-7. PubMed ID: 21628492
[TBL] [Abstract][Full Text] [Related]
12. Controlled major histocompatibility complex-T cell receptor signaling allows efficient generation of functional, antigen-specific CD8+ T cells from embryonic stem cells and thymic progenitors.
Lin J; Nie H; Tucker PW; Roy K
Tissue Eng Part A; 2010 Sep; 16(9):2709-20. PubMed ID: 20380488
[TBL] [Abstract][Full Text] [Related]
13. Directed differentiation of induced pluripotent stem cells towards T lymphocytes.
Lei F; Haque R; Xiong X; Song J
J Vis Exp; 2012 May; (63):e3986. PubMed ID: 22617911
[TBL] [Abstract][Full Text] [Related]
14. A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.
Iriguchi S; Yasui Y; Kawai Y; Arima S; Kunitomo M; Sato T; Ueda T; Minagawa A; Mishima Y; Yanagawa N; Baba Y; Miyake Y; Nakayama K; Takiguchi M; Shinohara T; Nakatsura T; Yasukawa M; Kassai Y; Hayashi A; Kaneko S
Nat Commun; 2021 Jan; 12(1):430. PubMed ID: 33462228
[TBL] [Abstract][Full Text] [Related]
15. Development of Immune Cell Therapy Using T Cells Generated from Pluripotent Stem Cells.
Kawamoto H; Masuda K; Nagano S
Adv Exp Med Biol; 2024; 1444():207-217. PubMed ID: 38467982
[TBL] [Abstract][Full Text] [Related]
16. Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes.
Saito H; Iwabuchi K; Fusaki N; Ito F
J Vis Exp; 2016 Nov; (117):. PubMed ID: 27911363
[TBL] [Abstract][Full Text] [Related]
17. Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.
Minagawa A; Yoshikawa T; Yasukawa M; Hotta A; Kunitomo M; Iriguchi S; Takiguchi M; Kassai Y; Imai E; Yasui Y; Kawai Y; Zhang R; Uemura Y; Miyoshi H; Nakanishi M; Watanabe A; Hayashi A; Kawana K; Fujii T; Nakatsura T; Kaneko S
Cell Stem Cell; 2018 Dec; 23(6):850-858.e4. PubMed ID: 30449714
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products.
Sadeqi Nezhad M; Abdollahpour-Alitappeh M; Rezaei B; Yazdanifar M; Seifalian AM
Pharm Res; 2021 Jun; 38(6):931-945. PubMed ID: 34114161
[TBL] [Abstract][Full Text] [Related]
19. Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System.
Vizcardo R; Klemen ND; Islam SMR; Gurusamy D; Tamaoki N; Yamada D; Koseki H; Kidder BL; Yu Z; Jia L; Henning AN; Good ML; Bosch-Marce M; Maeda T; Liu C; Abdullaev Z; Pack S; Palmer DC; Stroncek DF; Ito F; Flomerfelt FA; Kruhlak MJ; Restifo NP
Cell Rep; 2018 Mar; 22(12):3175-3190. PubMed ID: 29562175
[TBL] [Abstract][Full Text] [Related]
20. Generation of Antigen-Specific T Cells from Human Induced Pluripotent Stem Cells.
Nishimura T; Nakauchi H
Methods Mol Biol; 2019; 1899():25-40. PubMed ID: 30649763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
